BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34896179)

  • 61. The relationship of neuropsychiatric symptoms with inflammatory markers in the hippocampus and cingulate cortex of bipolar disorder subjects: A post-mortem study.
    Nascimento C; Villela Nunes P; Paraizo Leite RE; Grinberg LT; Suemoto CK; Lafer B
    J Psychiatr Res; 2024 May; 173():25-33. PubMed ID: 38479345
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Early intervention in bipolar affective disorders: Why, when and how].
    Pouchon A; Fakra E; Haesebaert F; Legrand G; Rigon M; Schmitt E; Conus P; Bougerol T; Polosan M; Dondé C
    Encephale; 2022 Feb; 48(1):60-69. PubMed ID: 34565543
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Brain-derived neurotrophic factor (BDNF) and bipolar disorder.
    Chiou YJ; Huang TL
    Psychiatry Res; 2019 Apr; 274():395-399. PubMed ID: 30852433
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course.
    Miller S; Hallmayer J; Wang PW; Hill SJ; Johnson SL; Ketter TA
    J Psychiatr Res; 2013 Feb; 47(2):252-8. PubMed ID: 23182421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients.
    Dell'Osso B; D'Addario C; Carlotta Palazzo M; Benatti B; Camuri G; Galimberti D; Fenoglio C; Scarpini E; Di Francesco A; Maccarrone M; Altamura AC
    J Affect Disord; 2014 Sep; 166():330-3. PubMed ID: 25012449
    [TBL] [Abstract][Full Text] [Related]  

  • 66. C-reactive protein, brain-derived neurotrophic factor, interleukin-2, and stressful life events in drug-naive first-episode and recurrent depression: A cross-sectional study.
    Jeenger J; Singroha V; Sharma M; Mathur DM
    Indian J Psychiatry; 2018; 60(3):334-339. PubMed ID: 30405261
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preliminary study of structural magnetic resonance imaging phenotypes related to genetic variation in Interleukin-1β rs16944 in adolescents with Bipolar Disorder.
    Shonibare DO; Patel R; Islam AH; Metcalfe AWS; Fiksenbaum L; Kennedy JL; Freeman N; MacIntosh BJ; Goldstein BI
    J Psychiatr Res; 2020 Mar; 122():33-41. PubMed ID: 31918351
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Markers of Inflammation and Monoamine Metabolism Indicate Accelerated Aging in Bipolar Disorder.
    van den Ameele S; Fuchs D; Coppens V; de Boer P; Timmers M; Sabbe B; Morrens M
    Front Psychiatry; 2018; 9():250. PubMed ID: 29962973
    [No Abstract]   [Full Text] [Related]  

  • 69. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients.
    de Oliveira GS; Ceresér KM; Fernandes BS; Kauer-Sant'Anna M; Fries GR; Stertz L; Aguiar B; Pfaffenseller B; Kapczinski F
    J Psychiatr Res; 2009 Sep; 43(14):1171-4. PubMed ID: 19473667
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparison study of metabolic profiles, immunity, and brain gray matter volumes between patients with bipolar disorder and depressive disorder.
    Bai YM; Chen MH; Hsu JW; Huang KL; Tu PC; Chang WC; Su TP; Li CT; Lin WC; Tsai SJ
    J Neuroinflammation; 2020 Jan; 17(1):42. PubMed ID: 32000805
    [TBL] [Abstract][Full Text] [Related]  

  • 71. sVCAM-1, sICAM-1, TNF-α and IL-6 levels in bipolar disorder type I: Acute, longitudinal and therapeutic implications.
    Pantović-Stefanović M; Petronijević N; Dunjić-Kostić B; Velimirović M; Nikolić T; Jurišić V; Lačković M; Damjanović A; Totić-Poznanović S; Jovanović AA; Ivković M
    World J Biol Psychiatry; 2018; 19(sup2):S41-S51. PubMed ID: 27841086
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Links between objective sleep and sleep variability measures and inflammatory markers in adults with bipolar disorder.
    Lee E; Ramsey M; Malhotra A; Ancoli-Israel S; Kaufmann CN; Soontornniyomkij B; Graham SA; Depp C; Eyler LT
    J Psychiatr Res; 2021 Feb; 134():8-14. PubMed ID: 33360441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.
    Wang TY; Lee SY; Chen SL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
    Sci Rep; 2016 Jun; 6():27431. PubMed ID: 27270858
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder.
    Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sex-based dimorphisms in expression of BDNF and BACE1 in bipolar patients.
    Ghafouri-Fard S; Taheri M; Arsang-Jang S; Kholghi Oskooei V; Omrani MD
    Compr Psychiatry; 2019 May; 91():29-33. PubMed ID: 30979423
    [TBL] [Abstract][Full Text] [Related]  

  • 76. BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder.
    Zeni CP; Tramontina S; Aguiar BW; Salatino-Oliveira A; Pheula GF; Sharma A; Stertz L; Moreira Maia CR; Hutz M; Kapczinski FP; Rohde LA
    Acta Psychiatr Scand; 2016 Sep; 134(3):268-74. PubMed ID: 27209073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlation between interleukin-6 levels and methadone maintenance therapy outcomes.
    Lu RB; Wang TY; Lee SY; Chen SL; Chang YH; See Chen P; Lin SH; Chu CH; Huang SY; Tzeng NS; Lee IH; Chin Chen K; Kuang Yang Y; Chen P; Chen SH; Hong JS
    Drug Alcohol Depend; 2019 Nov; 204():107516. PubMed ID: 31513981
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder.
    Chepenik LG; Fredericks C; Papademetris X; Spencer L; Lacadie C; Wang F; Pittman B; Duncan JS; Staib LH; Duman RS; Gelernter J; Blumberg HP
    Neuropsychopharmacology; 2009 Mar; 34(4):944-51. PubMed ID: 18704093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical staging and serum cytokines in bipolar patients during euthymia.
    Tatay-Manteiga A; Balanzá-Martínez V; Bristot G; Tabarés-Seisdedos R; Kapczinski F; Cauli O
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():194-201. PubMed ID: 28445689
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder.
    Kapczinski F; Frey BN; Kauer-Sant'Anna M; Grassi-Oliveira R
    Expert Rev Neurother; 2008 Jul; 8(7):1101-13. PubMed ID: 18590480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.